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Aim
The CD4 depletion in the chronic phase of HIV infec-
tion is mostly due to the loss of uninfected cells. We
previously showed that this lost was related to the
expression of NKp44L, a cellular ligand of the natural
cytotoxicity receptor NKp44, which renders CD4 cells
sensitive to NK killing. NKp44L is specially induced by
the highly conserved 3S motif of the HIV-1 gp41 envel-
ope protein. We also have shown that NKp44L is pre-
sent on bystander non-infected CD4 cells, but absent
from HIV-infected cells, through a Nef-dependent
mechanism. In this study we sought to determine
whether the loss of uninfected bystander CD4 cells
could be prevented by a 3S therapeutic immunization in
a macaque model chronically infected with SHIV162P3.
Methods
Ten cynomolgus macaques were chronically infected
with SHIV162P3. Seven months after infection, the ani-
mals were primed/boosted in IFA with 3S-KLH or free
KLH, as control. Lymphocyte samples and sera were
periodically tested, while secondary lymphoid organs
after euthanasia, at 7 months post-immunization.
Results
We discovered that immunization with 3S-KLH, signifi-
cantly decreases of NKp44L expression on CD4 cells,
and NK cells cytotoxicity against autologous CD4 cells,
when compared to infected group with free KLH-immu-
nization. Interestingly, the frequency of CD4 central
memory T cells from immunized animals remains
stable, while decreasing in the control group. Finally, in
lymphoid organs, including spleen, lymph node and gut,
a significant decrease of the cell-activation and the cas-
pase-3 dependent apoptosis was observed in macaques
immunized by 3S-KLH, as compared to control.
Discussion
These results emphasize the deleterious role of NK cells
on CD4 depletion and demonstrate for the first time, its
prevention by a therapeutic vaccine, which should also
inhibits and/or delay disease evolution to AIDS.
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